Dermatest

“Best anti-cellulite action of all preparations evaluated by Dermatest to date.”

Results

Marked increase in collagen fibers and decrease in volume of fat lobules
Continuously improved efficacy measured up to the 12th week
All those tested reported significantly improved elasticity

Study design

In-vivo study meeting clinical dermatology criteria with skin689® Anti-cellulite Cream

Applied to the right thigh, comparison of untreated/treated areas, skin elasticity measured using Cutometer MPA 580, fat globules measured using skin ultrasound (Skin Scanner DUB)

Skin elasticity

Skin elasticity was measured using a cutometer and was found to have improved in all subjects. After four weeks by an average of 13%, after twelve weeks by an average of 22% – up to 33%. A positive effect was observed in all test subjects after 4 weeks.*

0%
Skin elasticity

22% improvement in skin elasticity after twelve weeks

0%
Volumes of fat globules

44% reduction in fat globule volumes after 12 weeks

Volumes of fat globules

An astonishing effect was observed when measuring protruding fat globules using ultrasound, those responsible for the skin tone typical of cellulite: the volume of fat globules decreased in all subjects. After four weeks by an average of 23%, and after twelve weeks the shrinkage was 44% on average – and up to 58%. According to the independent research institute, such effective anti-cellulite action has not yet been observed in any competing product.*

*) Results from in-vivo studies meeting clinical dermatology criteria at independent institutes using objective measures of efficacy; Individual results may vary

proDERM

“Anti-cellulite Cream from skin689® shows visible anti-cellulite effects.”

More collagen fibers for tighter, firmer skin.

Results

Significant visible improvement in 70% of users confirmed by experts using scientific macro photos*

Marked increase in collagen fibers and decrease in fat globule volumes detected using ultrasound measurement

Study design

In-vivo study meeting clinical dermatology criteria with skin689® Anti-cellulite Cream

Applied to one thigh only, comparison of untreated/treated areas after 85 days and assessment of each photo by each of 24 trained experts who did not know where the treatment was carried out or when the photo was taken; rating on a scale from 1 (least cellulite) to 3 (most cellulite); no massage or similar, meaning the effect measured can be attributed in full to the product or active ingredient.

DermCom®

The world’s first active ingredient with in-vivo proof of collagen and elastin regeneration, plus fat reduction

DermCom®

stimulates keratinocytes to secrete growth factors, which significantly improves the synthesis of collagen and elastin in the skin – for firmer, more elastic skin. One clinical study found 117% more collagen and 25% more elastin after just two weeks.

PTAheute

“After just four weeks of use, 75% of the pharmacy technicians surveyed confirmed a reduction in cellulite.”

Study design

The survey was directed at qualified pharmacy technicians and participants were selected in conjunction with “PTAheute” magazine.

Questionnaires completed after 4 weeks of using the Anti-cellulite Cream from skin689®.

Results

After just 4 weeks, 75% of pharmacy technicians surveyed confirmed a reduction in cellulite, 80% with a skin-firming effect and 74% with an improvement in skin elasticity*

Sederma

“8% thinner layer of fatty tissue in the skin within 4 weeks with CoAXEL®.”

Results

Significant reduction in the layer of fatty tissue in the skin after just 4 weeks

Study design

In-vivo study on CoAXEL® based on clinical dermatology criteria

Applied to one thigh and a placebo on the other, neither subjects nor investigators knowing which side had the placebo product (double-blind)

Measurement of skin thickness (hypodermis) after 4 weeks using ultrasound scanner.

DERMASCAN A (subjects who lost more than one kilogram in weight during the test period were not included)

*) Results from in-vivo studies meeting clinical dermatology criteria at independent institutes using objective measures of efficacy; Individual results may vary